Thus, in cases where TGF-β induces apoptosis and growth inhibition [46, 47], TMEPAI has the potential to counteract not only the growth inhibitory effects of TGF-β but also its pro- apoptotic actions by activating Akt, thereby contributing to tumor promotion by TGF-β. This evidence concerns the gene AKT1 and neoplasm.